The largest community of pharma leaders

EXUMA Biotechnology Expands Leadership Team with Appointment of Chief Medical Officer and Chief Financial Officer

SHANGHAI & WEST PALM BEACH, Fla.–(BUSINESS WIRE)–EXUMA Biotechnology, a clinical-stage biotechnology company discovering and developing CAR-T products for solid tumors and affiliate of F1 Oncology, Inc., announced today the expansion of its leadership team with the appointment of Wendy Li, M.D. as Chief Medical Officer and James Samuels as Chief Financial Officer. “It’s been a successful quarter for EXUMA with the positive announcement of interim results from two first-in-human solid tumor CA….

 

 

http://www.businesswire.com/news/home/20190618005833/en/EXUMA-Biotechnology-Expands-Leadership-Team-Appointment-Chief/

Recent Articles

Health Canada Approves REBLOZYL® (luspatercept), New Class of Treatment for Adult Patients Living with Beta Thalassemia

MONTREAL & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Bristol Myers Squibb Canada (BMS) and Acceleron...

Orb Health Names Healthcare Visionary Entrepreneur and Investor Sheila Schweitzer to Board of Directors

RICHARDSON, Texas.--(BUSINESS WIRE)-- #aco--Orb Health, the leader in Chronic Care Management...

U.S. FDA Approves Pfizer’s XELJANZ® (tofacitinib) for the Treatment of Active Polyarticular Course Juvenile Idiopathic Arthritis

NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) announced today that the United...

TriSalus Life Sciences Appoints Steven Katz, M.D., Chief Medical Officer

DENVER & CHICAGO--(BUSINESS WIRE)-- #TriSalus--TriSalus appoints Steven Katz, M.D., as its...

Concert Pharmaceuticals Completes Enrollment in CTP-692 Phase 2 Trial in Patients with Schizophrenia

LEXINGTON, Mass.--(BUSINESS WIRE)---- $CNCE #CNCE--Concert completed enrollment in its Phase 2...
2020 Call for Writers

Are you looking to inspire others in the pharma industry through your writing? You’re invited to submit your articles to become a Featured Writer for The Pharmaceutical Marketing Group website.